AAAAAA

   
Results: 1-18 |
Results: 18
A critique of the eleven randomised trials of high-dose chemotherapy for breast cancer
Authors: Antman, KH
Citation: Kh. Antman, A critique of the eleven randomised trials of high-dose chemotherapy for breast cancer, EUR J CANC, 37(2), 2001, pp. 173-179
Randomized trials of high dose chemotherapy for breast cancer
Authors: Antman, KH
Citation: Kh. Antman, Randomized trials of high dose chemotherapy for breast cancer, BBA-REV CAN, 1471(3), 2001, pp. M89-M98
Protocol for the examination of specimens from patients with tumors of theperitoneum - A basis for checklists
Authors: Scully, RE Antman, KH
Citation: Re. Scully et Kh. Antman, Protocol for the examination of specimens from patients with tumors of theperitoneum - A basis for checklists, ARCH PATH L, 125(9), 2001, pp. 1174-1176
Decision analysis of tamoxifen for the prevention of invasive breast cancer
Authors: Grann, VR Sundararajan, V Jacobson, JS Whang, W Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Decision analysis of tamoxifen for the prevention of invasive breast cancer, CANCER J, 6(3), 2000, pp. 169-178
High-dose chemotherapy in breast cancer: The end of the beginning?
Authors: Antman, KH
Citation: Kh. Antman, High-dose chemotherapy in breast cancer: The end of the beginning?, BIOL BLOOD, 6(5), 2000, pp. 469-475
Prevention with tamoxifen or other hormones versus prophylactic surgery inBRCA1/2-positive women: A decision analysis
Authors: Grann, VR Jacobson, JS Whang, W Hershman, D Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Prevention with tamoxifen or other hormones versus prophylactic surgery inBRCA1/2-positive women: A decision analysis, CA J SCI AM, 6(1), 2000, pp. 13-20
CD34(+) cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer
Authors: Papadopoulos, KP Ayello, J Reiss, RF Troxel, A Kaufman, E Vahdat, LT Antman, KH Hesdorffer, CS
Citation: Kp. Papadopoulos et al., CD34(+) cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer, J HEMATH ST, 8(4), 1999, pp. 357-363
International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury
Authors: Shipp, MA Abeloff, MD Antman, KH Carroll, G Hagenbeek, A Loeffler, M Montserrat, E Radford, JA Salles, G Schmitz, N Symann, M Armitage, JO Coiffier, B Philip, T
Citation: Ma. Shipp et al., International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury, ANN ONCOL, 10(1), 1999, pp. 13-19
Re-evaluation of benefits of BRCA1/2 testing - Reply
Authors: Grann, VR Whang, W Jacobson, JS Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Re-evaluation of benefits of BRCA1/2 testing - Reply, J CL ONCOL, 17(6), 1999, pp. 1962-1962
Dose-intensive therapy for limited-stage small-cell lung cancer: Long-termoutcome
Authors: Elias, A Ibrahim, J Skarin, AT Wheeler, C McCauley, M Ayash, L Richardson, P Schnipper, L Antman, KH Frei, E
Citation: A. Elias et al., Dose-intensive therapy for limited-stage small-cell lung cancer: Long-termoutcome, J CL ONCOL, 17(4), 1999, pp. 1175-1184
Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2
Authors: Grann, VR Whang, W Jacobson, JS Heitjan, DF Antman, KH Neugut, AI
Citation: Vr. Grann et al., Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2, J CL ONCOL, 17(2), 1999, pp. 494-500
Critique of the high-dose chemotherapy studies in breast cancer: A positive look at the data
Authors: Antman, KH
Citation: Kh. Antman, Critique of the high-dose chemotherapy studies in breast cancer: A positive look at the data, J CL ONCOL, 17(11), 1999, pp. 30-34
International consensus conference on high-dose therapy with hematopoieticstem cell transplantation in aggressive non-hodgkin's lymphomas: Report ofthe jury
Authors: Shipp, MA Abeloff, MD Antman, KH Carroll, G Hagenbeek, A Loeffler, M Montserrat, E Radford, JA Salles, G Schmitz, N Symann, M Armitage, JO Philip, T Coiffier, B
Citation: Ma. Shipp et al., International consensus conference on high-dose therapy with hematopoieticstem cell transplantation in aggressive non-hodgkin's lymphomas: Report ofthe jury, J CL ONCOL, 17(1), 1999, pp. 423-429
Autotransplants in men with breast cancer
Authors: McCarthy, PL Hurd, DD Rowlings, PA Crump, M Gale, RP Lazarus, HM Vaughan, WP Weinberger, BB Wiemann, MC Freytes, CO Cirenza, E Antman, KH
Citation: Pl. Mccarthy et al., Autotransplants in men with breast cancer, BONE MAR TR, 24(4), 1999, pp. 365-368
A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors
Authors: Papadopoulos, KP Balmaceda, C Fetell, M Kaufman, E Vahdat, LT Bruce, J Sisti, M Isaacson, S De LaPaz, R Savage, DG Troxel, A Antman, KH Hesdorffer, CS
Citation: Kp. Papadopoulos et al., A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors, J NEURO-ONC, 44(2), 1999, pp. 155-162
High-dose chemotherapy for breast cancer
Authors: Antman, KH Heitjan, DF Hortobagyi, GN
Citation: Kh. Antman et al., High-dose chemotherapy for breast cancer, J AM MED A, 282(18), 1999, pp. 1701-1703
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer
Authors: Rowlings, PA Williams, SF Antman, KH Fields, KK Fay, JW Reed, E Pelz, CJ Klein, JP Sobocinski, KA Kennedy, MJ Freytes, CO McCarthy, PL Herzig, RH Stadtmauer, EA Lazarus, HM Pecora, AL Bitran, JD Wolff, SN Gale, RP Armitage, JO Vaughan, WP Spitzer, G Horowitz, MM
Citation: Pa. Rowlings et al., Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer, J AM MED A, 282(14), 1999, pp. 1335-1343
Sarcomas
Authors: Keohan, ML Antman, KH
Citation: Ml. Keohan et Kh. Antman, Sarcomas, MULTIPLE PRIMARY CANCERS, 1999, pp. 417-430
Risultati: 1-18 |